The present invention relates to association of one or more polymorphisms located in the human NHP2L1 , PACSIN2, SERHL, PIPPIN, BRD1 , EP300, FAM19A5 and/or GPR24 genes to the occurrence of schizophrenia and/or bipolar disord er. The invention relates both to methods for diagnosing a predisposition to said diseases and for treating subjects having said diseases.
METHOD FOR DIAGNOSIS AND TREATMENT OF A MENTAL DISEASE